CAMBRIDGE, Mass., Nov. 12, 2021 — Editas Medicine, Inc. (Nasdaq: EDIT), a genome editing company, announced preclinical data on its progress in the development of novel engineered induced pluripotent stem cell (iPSC)-derived natural killer cells (iNKs) for the treatment of cancer. In the presentation, the Company showed a new method to achieve high-levels of expression of CD16 and Interleukin-15 (IL-15) in iNK cells by using the Company’s proprietary CRISPR/Cas12a-mediated SLEEK (SeLection by Essential-gene Exon Knock-in) technology to simultaneously knock-in both functional genes. The modifications resulted in improved serial tumor killing and dramatically increased NK cell persistence. [Read more…]
Because cord blood present within a newborn’s umbilical is rich with stem cells, it can be collected and stored for future medical use.
Altamonte Springs, FL, October 29, 2021 — Cord for Life®, a full-service cord blood bank with over 25 years of experience, today announced plans to conduct a clinical trial to treat lower back pain arising from the Sacroiliac Joint (SIJ) using a biological therapeutic derived from umbilical cord blood. [Read more…]
The cost of cord blood banking is extremely affordable due to heated competition. Families now have more options to choose from than ever before.
Cord blood banking is becoming an increasingly common practice. More and more, new parents are becoming aware of the benefits of storing their newborn’s umbilical cord blood – a rich source of stem cells that can be used for life-saving medical treatment in the future. However, the biggest barrier for many families, has been the price.
Today, more than 70% of the global cord blood market is controlled by the world’s 12 largest cord blood banking operators. This is an incredible figure, given that the the cord blood industry grew to over 400 market participants in the early 2000’s but has consolidated dramatically since that time. [Read more…]
Singapore, Sep 7, 2021 – Local family cord blood bank Cryoviva Singapore is continuing with its rapid geographic growth plans with an entry into the Bahrain market. This latest new market entry closely follows Cryoviva establishing a footprint in Dubai to serve couples in the UAE that are on the family way. [Read more…]